Memorial Sloan Kettering Cancer Center
New York, 10065, United States
NCT Number: NCT01412762
The purpose of this study is to learn more about what patients undergoing surgery for thyroid cancer expect from their surgery. Your input may help us to better prepare and inform patients about their disease and its treatment.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
New York, 10065, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The pre-operative interview will be within 4 weeks of planned surgery and the postoperative interview within 8 weeks of surgery completion. This initial study is designed to develop an instrument to measure patient preoperative expectations in this patient population.
Individual semi-structured qualitative interviews will be conducted with a total of 10 patients and 5 clinicians during this phase to identify and discuss levels of satisfaction, level of burden, potential obstacles to implementation, as well as suggestions for improving the intervention
Time frame: 2 year
This will be done by conducting qualitative semistructured interviews with 15 thyroid cancer patients (pre- and postoperatively) to identify recurring themes about their expectations regarding thyroid surgery.
Memorial Sloan Kettering Cancer Center
Other
Measuring Patient Expectations for Thyroid Surgery: Development of a Patient-Reported Outcomes Instrument
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01141309
Endocrine Gland Neoplasms, Endocrine System Diseases
Basking Ridge, New Jersey, United States
View Trial DetailsNCT04238624
Anaplastic Thyroid Cancer, BRAF Gene Mutation
Basking Ridge, New Jersey, United States
View Trial DetailsNCT03285230
Asthma, Basal Ganglia Diseases
Villejuif, France
View Trial DetailsNCT03196518
Endocrine Gland Neoplasms, Endocrine System Diseases
New York, United States
View Trial Details